# Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)

> **NCT03947034** · — · COMPLETED · sponsor: **Groupe Hospitalier Pitie-Salpetriere** · enrollment: 2700 (actual)

## Conditions studied

- Hyperammonemia
- Metabolic Disease
- Adverse Drug Event
- Drug Toxicity

## Interventions

- **DRUG:** Drugs inducing hyperammonemia

## Key facts

- **NCT ID:** NCT03947034
- **Lead sponsor:** Groupe Hospitalier Pitie-Salpetriere
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2020-05-30
- **Final completion:** 2023-04-04
- **Target enrollment:** 2700 (ACTUAL)
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03947034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03947034, "Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03947034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*